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A B S T R A C T
Hepatocellular carcinoma (HCC), the most common form of liver cancer, represents a health problem in hepatic
viruses-eradicating era because obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH) are considered
emerging pathogenic factors. Metabolic disorders underpin mitotic errors that lead to numerical and structural
chromosome aberrations in a significant proportion of cell divisions. Here, we review that genomically unstable
HCCs show evidence for a paradoxically DNA damage response (DDR) which leads to ongoing chromosome
segregation errors. The understanding of DDR induced by defective mitoses is crucial to our ability to develop or
improve liver cancer therapeutic strategies.
1. Introduction
Hepatocellular carcinoma (HCC) represents 85% of liver cancer and
is associated with chronic liver disease, mainly related to hepatitis B
virus (HBV), hepatitis C virus (HCV), and alcohol abuse. However, re-
cent studies identify nonalcoholic steatohepatitis (NASH) as the un-
derlying cause in 20% of patients. NASH is associated with obesity,
diabetes mellitus and histologically is characterized by steatosis, ne-
croinflammation, and cirrhosis [1]. However, in recent years several
studies have described the onset of HCC in NASH patients who do not
have cirrhosis yet. Importantly, HCC diagnosis is underestimated and
the disease is often asymptomatic for decades. Based on these epide-
miological data and on the role of obesity and diabetes as carcinogenic
factors, the efforts in understanding the rising of liver cancer in these
patients are fully justified. Hepatocarcinogenesis involves numerous
phenotypic and genotypic alterations investing both transformed he-
patocytes and stromal components. In particular, the interactions be-
tween stromal cells (e.g. myofibroblasts, monocytes/macrophages) and
transformed hepatocytes represent a crucial step in the process of tumor
progression. These observations have fueled the hypothesis that a
boosted hepatocyte turnover occurring in a context of metabolic liver
disease contributes to the induction of the chromosomal instability
(CIN) that represents one of the key features of HCC tumorigenesis. CIN
is sensed as DNA damage and induces a signaling pathway named DNA
damage response (DDR), Fig. 1 [2]. The DDR is involved in several
aspects of DNA integrity because it affects several cellular processes
such as mitosis, senescence, apoptosis.
In this Review we discuss the relationships between abnormal mi-
tosis and CIN with a special focus on how the involvement of DDR can
either increase or decrease the sensitivity of the current HCC treat-
ments. This pathway has a central role in mitotic genome segregation,
indeed the depletion of DDR components or their abnormal activation
during mitosis perturbs the process of accurate chromosome segrega-
tion. How various types of mitosis-linked DNA damage engage the DNA
damage signaling pathways and repair components is unknown. The
effects of activating the DDR during mitosis have remained obscure on
the basis that it is difficult to study, however recent findings reveal it
can paradoxically lead to deleterious effects on genome stability.
2. From chromosomal aberrations towards cancer
Abnormal chromosome number termed aneuploidy is the distin-
guishing feature of cancer cells, a state in which cells do not contain an
exact multiple of the haploid DNA content, of note the term aneuploidy
refers to a static feature. An important aspect in studying cancer an-
euploidy is to discriminate between the state of the karyotype and the
rate of karyotypic change [3]. Aneuploidy is not synonymous with CIN,
some tumors are stably aneuploid with a highly abnormal but fairly
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uniform karyotype. In other tumors, an increased rate of CIN generates
diverse karyotypes within a tumor, the term chromosomal instability
describes a rate of change i.e. a dynamic feature of chromosome pa-
thophysiology [4]. This affects chromosome number and structure and
is a characteristic of many cancer types including HCC, it is also asso-
ciated with the formation of extranuclear bodies that contain damaged
chromosome fragments or whole chromosomes [4,5]. Such micronuclei
were identified in regenerative and dysplastic nodules of the liver in-
dicating that CIN can be acquired already in early stage of hepato-
carcinogenesis. Polyploidy, an increase in DNA content by whole-
number multiples of the entire set of chromosomes, is also thought to be
a possible mechanism that contributes to liver carcinogenesis [6].
Polyploid cells are formed during oxidative damage to the liver and re-
growth of the liver after partial hepatectomy and are associated with a
pronounced increase in the population of polyploid cells development
in otherwise diploid organisms. A growing amount of evidence in-
dicates that polyploid cells also arise during a variety of pathological
conditions. Genetic instability in these cells might provide a route to
aneuploidy and CIN and thereby contribute to the development of
cancer [7,8].
Overall, chromosome alterations are classified in two groups: nu-
merical aberrations and structural aberrations. In numerical type,
usually, a whole chromosome is gained or loss due to cell division er-
rors. This results in deviation of chromosome content of the cell from
normal diploid state. Structural abnormalities include several chromo-
somal rearrangement such as translocations, inversions, deletions and
gene copy-number amplifications and mostly produced by un- or miss-
repaired breakages of DNA [9]. In 1890, the German pathologist David
von Hansemann identified that “the cancerous process begins with an
altered division of chromosomes after metaphase in a local tissue cell”
and proposed it as one of the main factor in tumorigenesis. In general
the karyotypes of cancerous cells have been usually considered with
50–90 chromosomes and in a complex form harboring a variety of
structural chromosomal changes. Such chromosomes content is very
important in cancer cell homeostasis. Of note, such karyotypic hetero-
geneity varies among the different cells of a given cancer and also from
one cancer to another and may also differ during stages of cancer in-
itiation, progression and invasion [10]. In some cancers karyotypic
pattern is specific providing the basis for chromosomes as diagnostic
tool in cancer. The best example is translocation of chromosomes 9:22
(Philadelphia chromosome) in 90% CML patients. By means of fluor-
escent in situ hybridization, in 1990, Christoph Lengauer showed that
aneuploidy is a progressive phenomenon which is due to CIN so it is not
just a passive and marginal product of transformation [9]. However,
much literature uses the aneuploidy and CIN terms in a common
meaning and produces ambiguity. It has been evidenced that chromo-
somal aberrations can accelerate the clonal evolution of cancer cells
under selective pressure by gain or loss of genetic materials. Besides, it
can also play an important role producing a balance and homeostasis
between cellular life and adaptation [11]. Liver cancer is not exception
from these events and HCC cells are also cells with aberrant chromo-
somes which harbor variety of genetic rearrangements including
translocations, deletions and gene amplifications. Some of these mod-
ifications are unique to special sub-types of HCC while the others are
common in types, these findings suggest that the observed down-
regulation of SLU7 in the cirrhotic liver could participate in the in-
duction of DNA damage, aneuploidy and genome instability which in
chronic liver injury precede HCC development [12]. Recently, a study
has linked caspase-8-dependent apoptosis to HCC development via
proliferation-associated DNA damage. Proliferation-associated replica-
tion stress, DNA damage, and genetic instability are detectable in
chronic liver disease (CLD) before any neoplastic changes occur both in
human CLD and murine CLD models, the study has identified that in-
creased hepatocyte apoptosis resulting in regenerative proliferation,
high DNA replication rate and DNA damage are important determinant
of hepatocarcinogenesis [13].
Along these lines, etiological factors of CLD and HCC represent
important features of CIN drive as well. Meaningfully, CIN has been
associated with TP53 mutations and related to HBV infection, HCCs
with a high histological grade show a high TP53 mutation rate, whereas
HCC with a low histological grade show a low TP53 mutation rate.
Genetic alterations in five Wnt pathway genes (CTNNB1, AXIN1,
FGF19, RSPO2, and APC) are significantly associated with the absence
of HBV infection. This last group of tumors includes HCV infection and
NASH-related HCCs.
3. Defective spindle-kinetochore-chromosome structures
Due to the importance of spindle-kinetochore interaction during cell
division, it is not surprising if any defects in spindle attachment is
connected to CIN. Such errors are common in cell divisions as the ki-
netochores connect to the microtubules by chance [14]. During the cell
division, to ensure the proper chromosome segregation over the two
daughter cells, each kinetochore has to connect to a single spindle pole
through a single kinetochore fiber, the process is termed as amphitelic
attachment and regulated under the activity of spindle assembly
Fig. 1. The neoplastic evolution of HCC proceeds
through a multi-step histological and genetic pro-
cess. Hyperplastic nodules of regenerating hepato-
cytes have normal karyotype and represent a po-
tential first step towards HCC. These lesions can
progress to dysplastic nodules which have activated
DNA damage signaling pathway with abnormal
chromosome features including numerical and
structural alterations. These dysplastic nodules can
evolve to stable and unstable HCC marked with re-
current regions of copy number change and allelic
imbalances.
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checkpoint (SAC). In fact, kinetochore is a complex disc-shaped protein
that connects the centromere into the spindle microtubules through the
cell division [15]. Besides, other actions have been attributed to the
kinetochores. These consist of establishment of centromeric hetero-
chromatin mediating the sister chromatids adhesion through the co-
hesin and sister chromatids segregation during anaphase. Of note, in
the absence of proper chromatids-kinetochore-microtubules attach-
ment, SAC error correction machinery induces the mitotic delay to
prevent starting the anaphase [16]. This happens through inhibition of
anaphase promoting complex (APC) to attach to its activator CDC20. In
a recent study by Tauchman et al., they showed that hyper-stable ki-
netochore–microtubule attachment satisfies the ‘wait-anaphase’ signal
produced by the SAC [17]. Several defects have been reported in HCC
cells in which kinetochore structure or orientation are damaged, these
include monotelic, syntelic and merotelic attachments [18,19]. In
monotelic attachment error, one of the sister kinetochores attaches to
microtubules from one pole, whereas the other remains unattached to
any microtubules. In such condition, the unattached kinetochores are
recognized by mitotic checkpoints producing anaphase initiation delay
through the inhibition of anaphase promoting complex. In syntelic at-
tachment, both sister kinetochores interact to the microtubules origi-
nating from the same pole. Merotelic kinetochore orientation is an error
in which a single kinetochore is bound by microtubules emanating from
both spindle poles. In human, several proteins like pRb, the kinesin-
related MCAK and Aurora B kinase have been recognized to correct or
prevent the merotelic attachment errors but is not clear if their absence
results in kinetochore architecture changes towards merotelic orienta-
tion or CIN [20]. Growing body of evidences demonstrate that spindle
defects especially merotelic structures can increase the chromosome
instability and boost the harboring cells of such error towards tumor-
igenesis. In HCC cells variety of spindle defects has been reported, Saeki
et al. have demonstrated that impaired mitotic assembly checkpoint in
HCC is associated with aneuploidy and aneuploid HCC cells (62.5%)
harbor the loss of this checkpoint [21].
4. Aberrant spindle morphology
Mitotic spindle is an apparatus which forms during cell division and
promotes sister chromatids segregation through the anaphase. The
mitotic spindle is composed of a variety of proteins among which tu-
bulins are predominant. The chromosomes attached to the tubulins via
the kinetochore proteins actively monitor spindle formation and pre-
vent premature anaphase onset. It has been evidenced that aberrant
morphology or orientation of mitotic spindle can be connected to
chromosome aneuploidy. Multipolar mitotic spindles are common
characteristics of many solid tumors which eventually lead to chro-
mosome segregation errors and CIN. Centrosome abnormalities play an
important role in formation of such multipolar mitotic spindles and
centrosome amplification is one the main cause of multipolar spindle
and can occur in TP53 mutated-HCC or HBV-infected hepatocytes [22].
Altered expression of a variety of genes have been reported to mediate
centrosome amplification. As an example, Nelsen et al. showed that
transient overexpression of cyclin D1 in normal hepatocytes results in
supernumerary centrosomes and abnormalities of the mitotic spindle
[23]. Furthermore, it has also been evidenced that nucleophosmin/
Ran/Crm1 complex mutations or its disruption due to HBV infection,
play an important role in centrosome duplication [22].
5. The mitotic checkpoint
To ensure the exact segregation of sister chromatids during mitosis,
eukaryotic cells express a variety of regulatory proteins termed mitotic
checkpoint which act in specific points along the cell cycle phases and
guarantee the proper division of the cells, Fig. 2 [27–26]. Therefore, it
is not surprising that any defect in mitotic checkpoint is connected with
aneuploidy, CIN and cancer [26]. Decreased expression as well as
mutations in mitotic checkpoint genes have been observed in HCC and
other tumors, however these events are rare. Mitotic checkpoint over-
expression is a more frequent observation in human tumors and is
sufficient to generate CIN in vivo and in vitro. Mitotic checkpoint
overactivation results in a prolonged mitosis and an increased incidence
of merotelic attachments and lagging chromosomes. Dysregulation of
mitotic checkpoint has been repeatedly reported in HCC cells which
eventually lead to aneuploidy and rearrangements in these cells. The
master regulators which have been described in HCC are BUBR1,
MAD1/2, BUB3, and CENP-A/E [27].
Human BubR1 is a serine/threonine protein kinase which is in-
volved in kinetochore activity to determine if chromosomes have
achieved alignment at the spindle equator [28]. Overexpression of
BubR1 at both mRNA and protein levels, has been described in HCC
especially in HBV antigen positive cases and was associated with larger
tumor size, higher histological grade, advanced pathological stage, poor
recurrence-free survival and worse prognosis [24]. BUB3 is one the key
factor in SAC and delays the start of anaphase restraining kinetochore
localization during metaphase [29]. The impairment of Bub3 and its
family members Bub1 has been reported in HCC. Mitotic arrest defi-
cient 2 (MAD2) is one the essential mitotic checkpoint which is in-
volved in metaphase-anaphase transition. In particular MAD2 gene is a
component of spindle assembly checkpoint that prevent anaphase until
all sister chromatid pairs have become bipolarly attached. The findings
using experimental mice models are conflicting, Mad2 overexpression
Fig. 2. The mitotic checkpoint signaling. The signal generators of this check-
point are unattached kinetochores. Kinetochore assembly recruits MAD2 (mi-
totic arrest deficient homologue 2), BUB1 (budding uninhibited by benzimi-
dazole), BUB3, BUBR1 to unattached kinetochores. The kinase activity of
BUBR1 is essential for checkpoint signaling. The actions of all of these com-
ponents are required for tight association with CDC20 (cell division-cycle 20) in
unattached kinetochores, preventing it from activating the anaphase-promoting
complex/cyclosome (APC/C) and thereby inhibiting ubiquitylation of securin.
Separase, the protease that cleaves the cohesins that hold sister chromatids
together, is inhibited by binding to securin.
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induces aneuploidy and tumorigenesis in mice model [30]. Conversely,
down regulation of Mad2 has been reported in human HCC samples and
is associated with defective mitotic responses [31]. However, knocking
out of both Mad2 and p53 in experimental mice model have been
connected with phenotypes resembling HCC including hepatocyte re-
generation, genomic instability and fibrotic tumor microenvironment.
Recently, Foijer et al. have described the consequences of deleting
MAD2L1 in murine thymocytes and hepatocytes. In both cell types,
rapidly growing tumors arise from cells that have lost Mad2l1 expres-
sion, tumorigenesis is promoted in both thymocytes and the liver by
heterozygous or homozygous deletion of Trp53, establishing the pivotal
role of Trp53 as a potent tumor suppressor [32].
Centromere protein E (CENP-E) and centromere protein H (CENP-H)
are both critical for mitotic checkpoint and move the replicated chro-
mosomes towards metaphase plate during the mitosis [33–35]. Re-
duced expression of CENP-E has been reported in HCC cell lines and
reduced expression increases the rate of aneuploidy in the cells [34].
Centromere protein A (CENP-A) is one of the important protein in
centromere formation and epigenetic process. CENP-A is a Histone H3-
like protein, which is required for the proper formation of centromeres
and kinetochores. CENP-A has been reported to be overexpressed in
HCC samples and mRNA targeting of this gene inhibits the tumor
growth in HCC cells [36]. CENP-A overexpression leads to ectopic ki-
netochore formation, resulting an increased numbers of erroneous mi-
crotubule-centromere attachments upon mitotic entry and chromosome
segregation defects. Liu et al. showed that overexpression of CENP-A
has been associated with Hepatitis B virus X protein in HCC tissues
[25].
Cell division cycle protein 20 (CDC20) is one the key element in
activation of anaphase-promoting complex/cyclosome (APC/C) to in-
itiate sister chromatid separation [37]. Overexpression of CDC20 has
been evidenced to be connected with tumor differentiation and pro-
gression of HCC [38].
Anaphase promoting complex/cyclosome (APC/C) is one the main
element in regulation of anaphase during the mitosis. The APC/C's main
function is to trigger anaphase beginning by tagging specific proteins
for degradation. The three major targets for degradation by the APC/C
are securin and cyclins. Securin releases separase (a protease) after
being degraded. The separase triggers the cleavage of cohesin, the
protein complex that binds sister chromatids together. It has been
documented that altered functions of APC/C play an important role in
genomic instability and tumorigenesis.
6. DNA damage checkpoint and DNA repair pathways
The defective maintenance of organized and proficient DNA is
detrimental for cellular equilibrium. Induction of DNA double-strand
breaks (DSBs) in normal cells by ionizing radiations or radiomimetic
drugs activates a DNA damage response that produces cell cycle arrest,
DNA injury repair, and progression of cell cycle. Several proteins are
connected with DNA damage signaling and repair, localizing at broken
sites in focal structures termed foci [39]. DSBs are detected by the
multiprotein complexes Mre11–Rad50–Nbs1 (MRN) and Ku70–Ku80,
that successively recruit the PI3-kinase–like kinases (PIKKs), such as
ataxia telangiectasia mutated (ATM), and DNA-dependent protein ki-
nases (DNA-PKcs). A main PIKK target is the C terminus of the histone
variant H2AX, whose phosphorylated serine 139 (S139) is stated as
γH2AX [40]. Phospho-S139 of H2AX is then recognized by BRCA1 C-
terminal domain (BRCT) domains of the DDR protein MDC1 (mediator
of DNA damage checkpoint 1). ATM-mediated phosphorylations to DSB
sites contributes to form γH2AX-MDC1 foci. MDC1 phosphorylated by
ATM recruits the RING-finger ubiquitin E3-ligase RNF8, which, at the
side of another ubiquitin E3-ligase, RNF168, produces DSB-associated
ubiquitylations on histones H2A and H2AX that, in turn, promote ac-
cumulation of p53-binding protein one (53BP1) and breast cancer type
1 susceptibility protein (BRCA1). DDR proteins gather in a
spatiotemporal manner at sites of DNA breaks instead of being recruited
as a preassembled macromolecules [41]. Furthermore, modifications
such as phosphorylation regulate the structure and activity of DDR
target proteins providing docking sites for other DDR proteins. In most
respects DDR proteins display phospho-binding motifs such as BRCT
(breast cancer C-terminal) or FHA (forkhead-associated domain) that
contribute to mediate the phospho-dependent assembly of DDR protein
complexes, Fig. 3. The DNA damage checkpoint kinase CHK2 is a
central effector of this response to DSBs. Human Chk2 is a 543-amino-
acid protein that consists of a N-terminal SQ/TQ cluster domain (SCD),
a central forkhead-associated (FHA) domain and a C-terminal serine/
threonine kinase domain. The SCD consists of multiple SQ/ TQ (Ser-
Gln/Thr-Gln) motifs with Thr68 being the primary site to be phos-
phorylated in response to DNA damage followed by phosphorylation of
Thr387 in the activation loop of the kinase domain [42]. Surprisingly,
CHK2-null mouse mutants are viable and do not develop spontaneous
tumors, even more wild type and ATM+/− mice develop HCC, at
9–12months, whereas ATM−/− mice remain refractory to diethylni-
trosamine induced HCC up to 15months [43]. These observations de-
serve further investigation regarding the precise mechanisms and
functions of DDR proteins in mitotic cells. The overexpression and ac-
tivation of the DDR proteins during mitosis perturbs several aspects of
mitosis, including mitotic timing, anaphase and cytokinesis inducing
defective chromosome segregations [44]. Kim et al. reported that
γH2AX foci were significantly increased in HBV-related liver cirrhosis
and HBV-related HCC. Importantly, dysplastic nodule showed a sig-
nificantly higher level of γH2AX compared with HCC [45]. HCC me-
chanism of progression is less well defined than that of other cancer
types. Hyperplastic nodules have normal karyotype and represent a
potential first step towards HCC. These lesions can progress to dys-
plastic nodules, which have abnormal chromosome features including
numerical and structural alterations. Loss of certain tumor suppressors
Fig. 3. Spatial organization of DDR protein accumulation at DNA DSBs. DDR
proteins accumulate at DNA double strand breaks (DSB) sites involving MDC1,
which binds histone H2AX, the MRN complex, and ATM kinase, which phos-
phorylates additional histone H2AX molecules. ATM-dependent phosphoryla-
tion of MDC1 on Thr-Gln-X–Phe (TQXF) motifs creates binding sites for the FHA
domain of CHK2.
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or gain of specific oncogenes promote cell division and this coincides
with stochastic defective mitoses which can cause DNA damage
[46,47]. The scenario is conceivable considering that massive dereg-
ulation of mitosis is incompatible with cell survival and can even be
tumor suppressive [46]. Therefore, subtle rather than massive mitotic
defects and DNA damage are expected to underlie CIN in HCC, allowing
a tolerable level of chromosome defects. Hepatocarcinogenesis with
lagging chromosomes elicits the expression of DNA damage response
protein Chk2, the overexpression of Chk2 and its mislocalization within
structures of the mitotic spindle contribute to sustain cell division and
chromosomes missegregation. DDR proteins must localize to the right
place at the right time to ensure the efficient signaling and repair of
DNA damage. Thus, in chromosomally unstable cancers activation of
the DDR may be a insidious phenomenon due to the intrinsic and en-
during level of DNA damage during mitosis [2]. More importantly,
these findings raise the possibility that mitoses in cancer cells have lost
the fine tuning of DDR proteins promoting genomic instability and
linking mitosis, DNA damage to numerical and structural chromosomal
aberrations.
7. The influence of chromosomal instability on HCC therapy
Low sensitivity of HCC cells to chemotherapy is partly due to multi-
drug resistant phenotype (MDR) of these cells. Although the exact
mechanism of such resistance is not clear, some signaling pathways
including drug efflux pump, HIF1-α signaling and CIN play an im-
portant role in modulation of HCC-associated MDR [48]. It has been
evidenced that chromosomal aberrations confer the MDR-phenotype in
cancer cells and eventually lead to treatment failure. Regarding HCC
treatment a variety of signaling pathways have been exploited, however
conventional oncogene-directed drugs are not usually effective. It
should not to be ignored that chromosomal alterations yield cancer cells
resistant against these agents, indeed the effectiveness of the drugs is
correlated with the degree of CIN. Therefore, targeting CIN-linked
signaling pathways seems to be an interesting approach. Immune-
checkpoint blockade represents a therapeutical tool with tremendous
potential in treatment of several form of cancer including HCC, there-
fore whether and how CIN influences immune evasion is of pivotal
interest to improve the efficacy of immune-checkpoint blockade. In-
deed, the effectiveness of immune-checkpoint inhibition is associated
with mutations which cause single amino acid substitutions as reported
in patients with melanoma, NSCLC, or cancers with DNA-mismatch-
repair deficiencies. Along these lines, CIN-producing pathways are
welcomed as most of the cancer cells are chromosomally altered.
Nevertheless, CIN can be also an obstacle producing defects in neoan-
tigens editing, defects in antigen presentation and inhibition of tumor
infiltration, or cytotoxic activities of immune cells [3]. Additionally,
DDR and CIN cause derangement of metabolic attitude of cancer cells
boosting glycolysis in the presence of dysfunctional mitochondria.
Therefore, cancer cells might compete with T cells for glucose in tu-
mors, and restricting T cell glucose metabolism causes lymphocyte
defects. Thus, therapies targeting DNA damage response/CIN that de-
crease glucose use by cancer cells could make glucose available for T
cells and enhance immune-effector functions to limit tumor growth
[49]. Revealing the cytogenetic signature of cancer cells is fundamental
in understanding the histogenesis, morphology and biology of cancer
cells, therefore cancer research have to turn its attention to uncover the
specific cytogenetic patterns of different cancer cells to evaluate them
as possible prognostic, diagnostic and therapeutic indicators. In fact,
CIN can produce heterogeneous gene expression in the cancerous cells
and affects the treatment responses by altering gene regulatory inter-
action and varying protein concentration. The cytogenetic character-
ization of solid tumors is challenging due to techniques difficulties,
although recent advances in functional genomics such as NGS tech-
nologies leverage these difficulties. Nowadays, genomic loss and gain
aberrations are easily detectable in clinical samples. The issue seems
promising in diagnosis of a rare and lethal subtype of HCC called fibro-
lamellar HCC (FL-HCC), tumor cells posses a 400 kb deletion on chro-
mosome 19 which produces in frame fusion of DNAJB1 gene encoding
heat shock protein B1 and cAMP-activated tyrosine kinase PRKACA as a
specific cancer driver [50]. Furthermore, other putative druggable
genes were reported in HCC through the integrated genomic ap-
proaches, these include genes Wnt/β-catenin, JAK-STAT, oxidative
stress and chromatin remodeling signaling pathways.
8. Conclusions
The relevance of the DDR during defective mitosis and CIN is only
beginning to be revealed including the proteins and the mechanisms
involved in the complicated process of chromosome segregation. In
normal cells with defective chromosome segregations and DNA da-
mage, the DDR promotes clearing of cells through a p53-dependent
mechanism. In cancer cells, which often lack a functional p53-signaling
pathway and a proficient apoptosis, overexpression and activation of
the DDR proteins and their mislocalization within the mitotic spindle
transform DNA damage into structural chromosomal defects. A deep
comprehension of this process is essential to our understanding of how
DNA damaging therapies influence genomic integrity and how to
modulate the mitotic DDR apparatus to improve classic chemotherapy
and the promising immunotherapy.
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